Journals / Türk Spor ve Egzersiz Dergisi / 2021 / Cilt: 23 - Sayı: 2

Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players

Pages
185–189
Publication Date
2021-08-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, more studies with athletes from different branches are needed to reveal the effect of DRD2 rs1800497 polymorphism on athletic performance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:According to the literature, the genetic makeup of athletes contributes to their athletic performance.
📊
Key Findings & Data:Athletic performance depends on genetic and environmental factors relating to the athlete.
💡
Conclusion & Impact:However, more studies with athletes from different branches are needed to reveal the effect of DRD2 rs1800497 polymorphism on athletic performance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:sports · genetics · polymorphism

Abstract

According to the literature, the genetic makeup of athletes contributes to their athletic performance. Athletic performance depends on genetic and environmental factors relating to the athlete. The study of sports genetics includes extensive research into identifying genes that affect athletic performance. Psychological factors affect athletic performance and so dopamine contributes to the determination of that performance. One of the neurotransmitters of the dopaminergic system is dopamine, which affects the athlete mentally and psychologically. The dopamine receptor D2 (DRD2) rs1800497 polymorphism affects the brain’s dopaminergic system and athletic performance. This study aimed to determine the genotype and allele distributions of the DRD2 rs180047 polymorphism in football players and compare them with the control group. For this purpose, 21 football players were enrolled in our study. Genotyping was performed by PCR after DNAs were isolated from buccal epithelial cells. When we examined the genotype distributions, the AG and GG were found as 5 (24%) and 16 (76%), respectively. No AA genotype was found for DRD2. When allelic distributions were examined in the athlete group, the A allele was counted as 5 (12%) and the G allele as 37 (88%). In our study cohort, the DRD2 rs1800497 polymorphism was found to be dominated by the GG genotype and the G allele. We believe that the DRD2 A allele is associated with addiction and thus with athletic performance. However, more studies with athletes from different branches are needed to reveal the effect of DRD2 rs1800497 polymorphism on athletic performance.

🔖

Cite This Article

ASLAN, B. T., YILMAZ, Ö. Ö., POLAT, T., ŞILAR, Ç., EKEN, B. F., DOĞAN, C. S., ULUCAN, K. (2021). Distribution of Dopamine Receptor 2 DRD2 rs1800497 Polymorphisms in Professional Football Players. Türk Spor ve Egzersiz Dergisi, Cilt: 23 - Sayı: 2, 185–189. https://ajindex.com/articles/384997

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Corak A, Kapıcı S, Sercan C, Akkoç O, Ulucan K. A pilot study for determination of anxiety related SLC6A4 promoter “S” and “L” alleles in healthy Turkish athletes. Cell Mol Biol (Noisy-le-grand). 2017
  2. 63(5): 29-31. doi: 10.14715/cmb/2017.63.5.6 2. Ulucan K. Literature review of Turkish sportsmen in terms of ACTN3 R577X polymorphism. Clin Exp Health Sci. 2016
  3. 44–47. doi: 10.5152/clinexphealthsci.2016.059 3. Polat T, Dogan CS, Dogan M, Akçay T, Ulucan K. Distribution of α ‑ actinin ‑ 3 rs1815739 and angiotensin ‑ 1 converting enzyme InDel polymorphisms in Turkish bodybuilders. Biomedical Reports. 2020
  4. 13(6): 1–5. doi: 10.3892/br.2020.1374 4. Eken BF, Akpınaroğlu C, Arslan KS, Sercan C, Ulucan K. Effects of genes to psychological factors in sports. J Neurobehav Sci. 2018
  5. 5(1): 56–61. doi: 10.5455/JNBS.1516796381 5. Hornykiewicz O. The action of dopamine on the arterial pressure of the guinea pig. Br J Pharmacol. 1958
  6. doi: 10.1111/j.1476-5381.1958.tb00197.x 6. Foley TE, Fleshner EM. Neuroplasticity of Dopamine Circuits After Exercise: Implications for Central Fatigue. Neuromolecular Med. 2008
  7. 67–80. doi: 10.1007/s12017-008-8032-3 7. Jaber M, Robinson SW, Missale C, Caron MG. Dopamine receptors and brain function. Neuropharmacology. 1996
  8. 1503–1519. doi: 10.1016/s0028-3908(96)00100-1 8. Melis M, Greco B, Tonini R. Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction. European Journal of Neuroscience. 2014
  9. 1189–1201. doi: 10.1111/ejn.12501 9. Berridge KC. Is Addiction a Brain Disease? Neuroethics. 2017
  10. 10(1): 29–33. doi: 10.1007/s12152-016-9286-3 10. Thompson J, Thomas N, Singleton A, Piggott ML, loyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. D2 dopamine receptor gene (DRD2) taq1 A polymorphism reduced dopamine D2 receptor bindingin the human striatum associated with A1 allele. Pharmacogenetics. 1997
  11. doi: 10.1097/00008571-199712000-00006 11. Gingrich JA, Caron MG. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci. 1993
  12. doi: 10.1146/annurev.ne.16.030193.001503 12. Drago J, Padungchaichot P, Accili D, Fuchs S. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants. Dev Neurosci. 1998
  13. 188–203. doi: 10.1159/000017313 13. Turner E, Ewing J, Shilling P, Smith TL, Irwin M, Schuckit M, Kelsoe JR. Lack of association between an